Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Cold-Eeze cold relief lozenges

This article was originally published in The Tan Sheet

Executive Summary

Cold-Eeze cold relief lozenges: Quigley Corp. says it will complete initial expansion of its Doylestown, Penn. manufacturing facility by mid-December to fulfill a $3.5 mil. backlog of purchase orders for the homeopathic cold product. "New purchase orders...have reached $500,000 per week," Quigley says Dec. 3, and the newly expanded facility will allow the firm to maintain production of "over $1 mil. of product per week." Further expansions are already planned. Cold-Eeze was studied by the Cleveland Clinic and found to "significantly shorten" the duration of cold symptoms in 100 test subjects ("The Tan Sheet" July 15, p. 19). The product is sold through national discount food and drug chains such as Walgreen's and Kmart...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086423

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel